Literature DB >> 34197595

Early Changes in Interferon Gene Expression and Antibody Responses Following Influenza Vaccination in Pregnant Women.

Raquel Giacomelli Cao1, Lisa Christian2,3, Zhaohui Xu1,4, Lisa Jaramillo1, Bennett Smith1, Erik A Karlsson5,6, Stacey Schultz-Cherry5, Asuncion Mejias1,7,4, Octavio Ramilo1,7,4.   

Abstract

BACKGROUND: Influenza immunization during pregnancy provides protection to the mother and the infant. Studies in adults and children with inactivated influenza vaccine have identified changes in immune gene expression that were correlated with antibody responses. The current study was performed to define baseline blood transcriptional profiles and changes induced by inactivated influenza vaccine in pregnant women and to identify correlates with antibody responses.
METHODS: Pregnant women were immunized with inactivated influenza vaccine during the 2013-2014 and 2014-2015 seasons. Blood samples were collected on day 0 (before vaccination) and on days 1 and 7 after vaccination for transcriptional profile analyses, and on days 0 and 30, along with delivery and cord blood samples, to measure antibody titers.
RESULTS: Transcriptional analysis demonstrated overexpression of interferon-stimulated genes (ISGs) on day 1 and of plasma cell genes on day 7. Prevaccination ISG expression and ISGs overexpressed on day 1 were significantly correlated with increased H3N2, B Yamagata, and B Victoria antibody titers. Plasma cell gene expression on day 7 was correlated with increased B Yamagata and B Victoria antibody titers. Compared with women who were vaccinated during the previous influenza season, those who were not showed more frequent significant correlations between ISGs and antibody titers.
CONCLUSIONS: Influenza vaccination in pregnant women resulted in enhanced expression of ISGs and plasma cell genes correlated with antibody responses. Brief summary: This study identified gene expression profiles of interferon-stimulated genes and plasma cells before vaccination and early after vaccination that were correlated with antibody responses in pregnant women vaccinated for influenza.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Interferon-stimulated genes (ISGs); antibodies; immunization; influenza vaccine; maternal immunization

Mesh:

Substances:

Year:  2022        PMID: 34197595      PMCID: PMC8915434          DOI: 10.1093/infdis/jiab345

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  44 in total

1.  Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine.

Authors:  Gianvincenzo Zuccotti; Laura Pogliani; Elena Pariani; Antonella Amendola; Alessandro Zanetti
Journal:  JAMA       Date:  2010-12-01       Impact factor: 56.272

2.  Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses.

Authors: 
Journal:  Sci Immunol       Date:  2017-08-25

3.  Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.

Authors:  Mark C Steinhoff; Joanne Katz; Janet A Englund; Subarna K Khatry; Laxman Shrestha; Jane Kuypers; Laveta Stewart; Luke C Mullany; Helen Y Chu; Steven C LeClerq; Naoko Kozuki; Monica McNeal; Adriana M Reedy; James M Tielsch
Journal:  Lancet Infect Dis       Date:  2017-05-15       Impact factor: 25.071

4.  Safety of influenza vaccination during pregnancy.

Authors:  Flor M Munoz; Anthony J Greisinger; Oscar A Wehmanen; Melanie E Mouzoon; James C Hoyle; Frances A Smith; W Paul Glezen
Journal:  Am J Obstet Gynecol       Date:  2005-04       Impact factor: 8.661

Review 5.  Influenza immunization during pregnancy: US regulatory perspective.

Authors:  Valerie Marshall; Marion Gruber
Journal:  Am J Obstet Gynecol       Date:  2012-07-09       Impact factor: 8.661

Review 6.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22

7.  Cytomegalovirus vaccines under clinical development.

Authors:  Mark R Schleiss
Journal:  J Virus Erad       Date:  2016-10-05

8.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Karen R Broder; Emmanuel B Walter; Joseph S Bresee; Alicia M Fry; Daniel B Jernigan
Journal:  MMWR Recomm Rep       Date:  2017-08-25

9.  Population-based incidence of severe acute respiratory virus infections among children aged <5 years in rural Bangladesh, June-October 2010.

Authors:  Sharifa Nasreen; Stephen P Luby; W Abdullah Brooks; Nusrat Homaira; Abdullah Al Mamun; Mejbah Uddin Bhuiyan; Mustafizur Rahman; Dilruba Ahmed; Jaynal Abedin; Mahmudur Rahman; A S M Alamgir; Alicia M Fry; Peter Kim Streatfield; Anisur Rahman; Joseph Bresee; Marc-Alain Widdowson; Eduardo Azziz-Baumgartner
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

Review 10.  Strategic priorities for respiratory syncytial virus (RSV) vaccine development.

Authors:  L J Anderson; P R Dormitzer; D J Nokes; R Rappuoli; A Roca; B S Graham
Journal:  Vaccine       Date:  2013-04-18       Impact factor: 3.641

View more
  1 in total

1.  Functional and structural modifications of influenza antibodies during pregnancy.

Authors:  Madeleine F Jennewein; Martina Kosikova; Francesca J Noelette; Peter Radvak; Carolyn M Boudreau; James D Campbell; Wilbur H Chen; Hang Xie; Galit Alter; Marcela F Pasetti
Journal:  iScience       Date:  2022-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.